Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
Pfizer(PFE) stock is priced at $27.02, giving the company a market capitalization of 154.44B. It carries a P/E multiple of 19.77 and pays a dividend yield of 6.4%.
As of 2026-03-10, Pfizer(PFE) stock has fluctuated between $26.53 and $27.29. The current price stands at $27.02, placing the stock +1.9% above today's low and -1.0% off the high.
Pfizer(PFE) shares are trading with a volume of 42.81M, against a daily average of 39.65M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.94 and a 52-week low of $20.92.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.94 and a 52-week low of $20.92.
PFE News
Technology Why BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-Up Licensing BridgeBio (BBIO) stock popped Tuesday on a notable shake-up in the pa...
Pfizer (PFE) just reported positive Phase 2 topline data for tilrekimig in adults with moderate to severe atopic dermatitis. The trial met its main efficacy goa...
Key Points Pfizer's per-share profit in 2025 declined as the company incurred significant impairment charges. The company also paid out more in dividends than...
Analyst ratings
55%
of 29 ratingsMore PFE News
Pfizer (PFE) said its Phase 2 study of tilrekimig (PF-07275315), a trispecific antibody for atopic dermatitis, showed positive results. The study met its prima...
Pfizer (PFE) announced positive topline results from a Phase 2 study investigating tilrekimig in adults with moderate to severe atopic dermatitis. The study met...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 70% Off TipRanks Premium Unlock hedge fund-lev...
Pfizer (NYSE:PFE) and Astellas report positive Phase 3 results for PADCEV plus Keytruda in muscle invasive bladder cancer. The combination is linked to lower r...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has launched a new Phase 1 study in China titled “A Phase 1, Open-label...
China's National Medical Products Administration has approved Pfizer Inc.’s (NYSE:PFE) ecnoglutide injection for chronic weight management in adults with overwe...
Pfizer (PFE) has received regulatory approval in China for its GLP-1 treatment Xianweiying for long-term weight management in overweight and obese adults. The a...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.